💸 The Tape

A Travis County judge granted a temporary restraining order on Friday blocking enforcement of some of the state's sweeping new hemp regulations that took effect March 31. The ruling, issued by Judge Maya Guerra Gamble, specifically targets rules that changed how THC levels are calculated — a shift that effectively banned the sale of smokable hemp products like flower and concentrate. Those products, according to industry groups and economists, accounted for the vast majority of hemp sales in the state.

The regulations, imposed by the Department of State Health Services (DSHS), also introduced dramatically higher annual fees: $5,000 per retail location (up from $150) and $10,000 per manufacturing facility (up from $250). Judge Gamble blocked the smokable hemp prohibition but notably declined to block the fee increases — a partial victory that still leaves many businesses under significant financial strain.

A coalition of businesses and industry organizations, including the Texas Hemp Business Council, filed suit earlier in the week arguing that DSHS exceeded its authority and adopted rules that would shutter hundreds of operations. Attorney Jason Snell told the court that the damage was already underway, describing it as "irreparable harm that is already occurring and is exponentially multiplying."

The numbers back up the urgency. More than 13,000 stores are registered to sell hemp products in Texas, with nearly 800 licensed manufacturers. For an industry of that scale, regulatory whiplash isn't just inconvenient — it's existential.

The Texas Attorney General's Office pushed back, with attorney Zachary Berg arguing the DSHS rules simply provided clarity on existing law. The restraining order holds for two weeks, with a hearing on a longer-term temporary injunction scheduled for April 23.

The Bigger Problem Nobody's Talking About

Here's the uncomfortable truth hovering over this entire fight: even if Texas hemp businesses win this legal battle, they're staring down a far larger threat on the horizon.

The federal hemp products ban set to take effect in November 2026 stands to reshape — or outright dismantle — the hemp-derived THC market nationwide. Under provisions working their way through federal regulatory channels, the loosely regulated ecosystem of hemp-derived cannabinoid products that exploded after the 2018 Farm Bill faces a dramatic tightening that could pull products like Delta-8 THC, smokable hemp flower, and a range of infused edibles and beverages off shelves across the country.

Viewed against that backdrop, the Texas DSHS fight starts to look less like a decisive industry battle and more like rearranging deck chairs. Businesses are spending legal fees and political capital fighting state-level regulations that may be rendered moot within 18 months by federal action that supersedes the entire framework.

That's not to say the current fight doesn't matter to the thousands of Texas retailers and manufacturers whose livelihoods depend on staying open through the next quarter. Short-term survival is a prerequisite for long-term strategy. But the industry's attention and resources may be better directed at the federal conversation, where the real existential threat is taking shape.

The Texas hemp market, like its counterparts across the country, was built on a regulatory gray area — the gap between what the Farm Bill technically permitted and what lawmakers actually intended. That gap is closing, both in Austin and in Washington. The businesses that survive will likely be those that saw the contraction coming and planned accordingly, rather than those that fought each skirmish without watching the larger battlefield.

For now, smokable hemp is legal again in Texas. The restraining order buys the industry two weeks of breathing room. But the clock ticking loudest isn't the one counting down to April 23 — it's the one counting down to November 2026.

📈 Dog Walkers

Tyson Opening NYC Consumption Lounge

The boxing legend has announced a Tyson 2.0 Consumption Lounge opening April 20 at 733 Flatbush Avenue in Brooklyn — a "premium consumption sanctuary" connected to Q Dispensary, which will carry Tyson 2.0 products alongside other high-end offerings.

For Tyson, who grew up in Brooklyn, the launch is personal. "It's full-circle being able to bring a consumption lounge to Brooklyn," he said. "This place is always home."

The 4/20 grand opening leans heavily into spectacle. A comedy showcase curated by Priya Blunts features performers from HBO, Netflix, and Comedy Central, including Maddy Smith, Sherrod Small, and Asha Ward — all performing in a venue built around an actual ring-style setup, because of course it is. DJs Omer Mil and JuandeOne handle the music, and the first 100 guests score complimentary gifts.

The Brooklyn location marks Tyson 2.0's continued expansion into East Coast markets, building on the brand's already significant global footprint. For a company that's turned a retired heavyweight's name into one of cannabis's most recognizable brands, planting a flag in New York feels less like a gamble and more like an overdue homecoming.

$AYRWF ( ▼ 12.5% ) Only Mostly Dead

AYR Wellness is undergoing the kind of corporate transformation that reads like a financial restructuring textbook — except this one involves weed, and the stakes are very real.

The vertically integrated U.S. multi-state operator has announced the initial closing of its previously disclosed restructuring transactions, beginning with the transfer of its Virginia operations into Arboretum Virginia LLC, a subsidiary of Arboretum Bidco LLC. Arboretum, established by AYR's senior secured noteholders as the designated purchaser, intends to operate under the trade name "Ayr Wellness" — same name, fundamentally different ownership structure.

Additional state-level operations will transfer into Arboretum as regulatory approvals come through on a state-by-state basis. Virginia is the first domino.

The financial architecture behind the deal centers on a $275 million senior secured delayed draw term loan — the Exit Facility — backstopped by Millstreet Capital Management with participation rights extended to existing noteholders. The facility carries a 13% annual interest rate, offers a payment-in-kind option for the first 24 months before switching to cash pay, and matures in five years. It's secured by a first lien on substantially all of Arboretum's assets.

Woven into the Exit Facility is a Take-Back Facility, into which obligations from Tranche A of AYR's existing $50 million bridge credit facility are being rolled over on a pari passu basis. Meanwhile, AYR's senior secured noteholders are exchanging their claims for equity interests in Arboretum Investments LLC, the ultimate parent entity — effectively converting debt into ownership, with dilution provisions for a management incentive plan and certain equity premiums.

If that sounds complicated, it is. But the intended outcome is straightforward: reduce leverage, improve cash flow, and give the operating business a cleaner balance sheet to work with going forward.

As for the original AYR Wellness entity, it's heading in a decidedly different direction. The company is progressing liquidation and wind-down proceedings under the Companies' Creditors Arrangement Act in the Supreme Court of British Columbia. The corporate shell is being unwound while the operating assets live on under new financial stewardship.

The restructuring reflects a broader reality across the U.S. cannabis industry: companies that expanded aggressively during the boom years are now reckoning with debt loads that the current market simply can't sustain. AYR's path — handing the keys to creditors while preserving operational continuity — may become a familiar playbook as the sector continues to mature through financial pressure.

🗞️ The News

📺 YouTube

How Media Gets the Cannabis Youth Conversation Wrong​​​​​​​​​​​​​​​​ | TDR Cannabis in 5

What we will cover:

✅ One of the most persistent myths in the cannabis debate is getting a full fact-check in this episode of TDR Cannabis in Five, presented by Flowhub. Host Shadd Dales tackles the claim that cannabis legalization increases youth access — and breaks down why that argument is not only misleading, but actually ignores where the real problem is coming from.

The truth is, licensed dispensaries are among the most strictly age-gated retail environments in North America. ID checks, compliance audits, seed-to-sale tracking, and heavy penalties for violations — the legal market has more guardrails in place than almost any other retail category. In many states, dispensaries actually outperform alcohol retailers in compliance checks.

The real issue? Unlicensed smoke shops and gas station counters selling unregulated hemp-derived synthetics like delta-8 — products with no testing, no labeling, and zero age verification. These operators exist completely outside the regulatory system, yet they’re constantly lumped in with licensed cannabis retailers by politicians and media personalities looking for a headline.

Shadd also looks at the data out of Canada, where federal legalization has not led to an explosion in youth consumption — and makes the case that good regulation actually protects minors better than prohibition ever could.

If protecting kids is truly the goal, the answer isn’t attacking the legal industry. It’s shutting down the illegal one.